Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novacare (NOV) breaking out... -- Ignore unavailable to you. Want to Upgrade?

To: Kelvin Taylor who wrote (301)	6/19/1998 1:51:00 AM
From: Todd D. Wiener	Respond to of 420

Kelvin- Obviously, my favorite is THQI. Good move with SMTC. THQI may pull back a bit. I suspect that tomorrow will keep THQI below $30. NOV seems to be the better buy, as compared to NCES (due to the technical strength). But they are both attractive as long term holdings at current prices. It might be good to split up the money between NOV and NCES. You could also buy a call option on THQI, if you want to make sure that you'll benefit from the upside. I think that the July 30 calls are the best bet now. I own all of them, so I like them all. Todd